BCL-2 As a Potential Therapeutic Target in Human Lupus Tubulointerstitial Inflammation.

被引：0
|
作者：
Ko, Kichul [1 ]
Yanez, Denisse [1 ]
Kaverina, Natalya [1 ]
Liarski, Vladimir M. [1 ]
Peng, Yahui [2 ]
Lan, Li [1 ]
Perper, Stuart [3 ]
Schwartz, Annette [3 ]
O'connor, Liz [3 ]
Souers, Andrew [4 ]
Elmore, Steven [4 ]
Olson, Lisa [3 ]
Giger, Maryellen L. [1 ]
Wang, Li Chun [3 ]
Clark, Marcus R. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Beijing Jiaotong Univ, Beijing, Peoples R China
[3] AbbVie Inc, AbbVie Biores Ctr, Worcester, MA USA
[4] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2839
引用
收藏
页码：S1241 / S1241
页数：1
相关论文
共 50 条
  • [31] Bcl-2 regulation of calcium signals contributes to CLL pathogenesis, a novel therapeutic target
    Distelhorst, Clark
    LEUKEMIA & LYMPHOMA, 2017, 58 : 115 - 116
  • [32] Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target
    Hosoya, Kazutaka
    Ozasa, Hiroaki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (03) : 689 - 693
  • [33] Bcl-2 Family Proteins as Therapeutic Targets
    Czabotar, Peter E.
    Lessene, Guillaume
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (28) : 3132 - 3148
  • [34] A newly identified G-quadruplex as a potential target regulating Bcl-2 expression
    Sun, Hongxia
    Xiang, Junfeng
    Shi, Yunhua
    Yang, Qianfan
    Guan, Aijiao
    Li, Qian
    Yu, Lijia
    Shang, Qian
    Zhang, Hong
    Tang, Yalin
    Xu, Guangzhi
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (10): : 3052 - 3057
  • [35] Therapeutic Inhibition Of Anti-Apoptotic BCL-2 Family Proteins In a Murine Model Of Lupus Nephritis
    Wang, Li Chun
    Perper, Stuart
    Perron, Danise
    Tarcsa, Edit
    Bardwell, Philip
    Mozaffarian, Neelufar
    Souers, Andrew
    Elmore, Steven
    Ghayur, Tariq
    Olson, Lisa
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S241 - S241
  • [36] Identification of SCRG1 as a Potential Therapeutic Target for Human Synovial Inflammation
    Liu, Guoqiang
    He, Guisong
    Zhang, Jie
    Zhang, Zhongmin
    Wang, Liang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] THERAPEUTIC INHIBITION OF ANTI-APOPTOTIC BCL-2 FAMILY PROTEINS IN A MURINE MODEL OF LUPUS NEPHRITIS
    Wang, L. C.
    Perper, S.
    Perron, D.
    Tarcsa, E.
    Bardwell, P.
    Mozaffarian, N.
    Souers, A.
    Elmore, S.
    Ghayur, T.
    Olson, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 79 - 79
  • [38] Machine Learning to Quantify In Situ Humoral Selection in Human Lupus Tubulointerstitial Inflammation
    Kinloch, Andrew J.
    Asano, Yuta
    Mohsin, Azam
    Henry, Carole
    Abraham, Rebecca
    Chang, Anthony
    Labno, Christine
    Wilson, Patrick C.
    Clark, Marcus R.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [39] Gene transfer to monocytes & macrophages: Potential target for gene therapy of intestinal inflammation.
    Barbara, G
    Vallance, BA
    Galeazzi, F
    Gauldie, J
    Collins, SM
    GASTROENTEROLOGY, 1997, 112 (04) : A927 - A927
  • [40] Vimentin Is a Dominant Target of In Situ Humoral Immunity in Human Lupus Tubulointerstitial Nephritis
    Kinloch, Andrew J.
    Chang, Anthony
    Ko, Kichul
    Dunand, Carole J. Henry
    Henderson, Scott
    Maienschein-Cline, Mark
    Kaverina, Natalya
    Rovin, Brad H.
    Ferrer, Marlene Salgado
    Wolfgeher, Don
    Liarski, Vladimir
    Haddon, D. James
    Utz, Paul J.
    Wilson, Patrick C.
    Clark, Marcus R.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (12) : 3359 - 3370
12345